CN1346675A - Chinese patent medicine for treating paraplegia - Google Patents
Chinese patent medicine for treating paraplegia Download PDFInfo
- Publication number
- CN1346675A CN1346675A CN01141625A CN01141625A CN1346675A CN 1346675 A CN1346675 A CN 1346675A CN 01141625 A CN01141625 A CN 01141625A CN 01141625 A CN01141625 A CN 01141625A CN 1346675 A CN1346675 A CN 1346675A
- Authority
- CN
- China
- Prior art keywords
- parts
- gram
- paraplegia
- chinese patent
- patent medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
A Chinese patent medicine for treating paraplegia is prepared from 12 Chinese-medicinal materials including astragalus root, leech, placenta, notoginseng, etc through pulverizing, mixing with boiled honey, and shaping honeyed pills or particles. It has high curative effect.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of paraplegia, specifically is the Chinese patent medicine of feedstock production with the Chinese herbal medicine.
Background technology
At present, the prevention that spinal cord injury causes paraplegia and treatment are one of important topics of current medical science and biology, Physiologic Studies, and Chinese scholars is all being explored and studied.Yet, all there are not obviously progress and effective Therapeutic Method up to now, therefore, spinal cord injury causes the patient of paraplegia can be found everywhere, and brings huge misery for countless families.
Summary of the invention
Technical problem to be solved by this invention just provides a kind of novel pure Chinese medicinal preparation, effectively treats paraplegia, recovers function convenient to both, promotes the spinal cord growth, makes it have the cure rate height, determined curative effect, and take characteristics such as have no side effect for a long time.
Medicine of the present invention is to make (consumption is a weight portion) by following component Chinese patent medicine honeyed pill or granule method for making routinely:
5~15 parts of 5~15 fens Asterias amurensis Lutkenes of 10~20 parts of Placenta Hominiss of 10~25 portions of Hirudos of the Radix Astragali
10~25 parts in 10~25 parts of Rhizoma Gastrodiaes of 5~15 parts of Radix Rehmanniaes Preparata of 5~15 parts of Ovum Eriocheir sinensis of Radix Notoginseng
5~15 parts of 5~15 parts of Cordyceps of 5~10 parts of Rhizoma Chuanxiongs of 5~10 parts of Ligamentum cervis of eupolyphage sece steleophaga
4~10 parts of Sanguis Draxonis
The present invention adopts traditional theory of Chinese medical science, and in conjunction with Zhitan secret recipe handed down from one's ancestors, the pure Chinese medicinal preparation of the effective drug development of repeated screening, have evident in efficacy, taking convenience, low price, and advantage such as without any side effects is the comparatively ideal medicine for the treatment of paraplegia at present.
Below provide three formulation Example of the present invention:
Side one, the Radix Astragali 13 gram Hirudos 13 gram Placenta Hominiss 7 gram Asterias amurensis Lutkenes 7 grams
Radix Notoginseng 7 gram Ovum Eriocheir sinensis 7 gram Radix Rehmanniaes Preparata 8 gram Rhizoma Gastrodiaes 11 grams
Eupolyphage sece steleophaga 6 gram Ligamentum cervis 6 gram Rhizoma Chuanxiongs 6 gram Cordyceps 6 grams
Sanguis Draxonis 7 grams
Side two, the Radix Astragali 15 gram Hirudos 14 gram Placenta Hominiss 9 gram Asterias amurensis Lutkenes 8 grams
Radix Notoginseng 8 gram Ovum Eriocheir sinensis 8 gram Radix Rehmanniaes Preparata 9 gram Rhizoma Gastrodiaes 13 grams
Eupolyphage sece steleophaga 6.5 gram Ligamentum cervis 6.5 gram Rhizoma Chuanxiongs 6.5 gram Cordyceps 6.5 grams
Sanguis Draxonis 10 grams
Side three, the Radix Astragali 18 gram Hirudos 15 gram Placenta Hominiss 11 gram Asterias amurensis Lutkenes 9 grams
Radix Notoginseng 10 gram Ovum Eriocheir sinensis 10 gram Radix Rehmanniaes Preparata 11 gram Rhizoma Gastrodiaes 15 grams
Eupolyphage sece steleophaga 8 gram Ligamentum cervis 7 gram Rhizoma Chuanxiongs 7 gram Cordyceps 8 grams
Sanguis Draxonis 4 grams
By above-mentioned formulation Example as can be seen, solution of the present invention is based on pathogenetic understanding and the Therapeutic Principle of motherland's medical science to " paraplegia ", achieve with reference to modern pharmacological research, from motherland's medicine treasure-house, filter out invigorating the kidney and strengthening the bones, the removing blood stasis dissipating blood stasis, channels sootheing and network vessel quickening, honor repose through natural plant, by the theory of Chinese medical science prescription, skim the cream off milk.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, to select the pure natural plant medicine be raw material in the present invention, and each component meets the pharmaceutical control law regulation. Sharp With the comprehensive function treatment " paraplegia " of each flavor Chinese medicine, no chemical analysis, nontoxic to human body.
2, the present invention need not decoct, no bitterness sense, taking convenience.
3, during the drug administration of the present invention, the combination with massaging effect can be more remarkable again, can when taking Do efficacy-enhancing ingredient with about 5 gram donkey-hide gelatin, curative effect can be more remarkable.
Claims (1)
1, a kind of Chinese patent medicine for the treatment of paraplegia is characterized in that it is honeyed pill or the granule of being made by following proportion raw material.
5~15 parts of 5~15 fens Asterias amurensis Lutkenes of 10~20 parts of Placenta Hominiss of 10~25 portions of Hirudos of the Radix Astragali
10~25 parts in 10~25 parts of Rhizoma Gastrodiaes of 5~15 parts of Radix Rehmanniaes Preparata of 5~15 parts of Ovum Eriocheir sinensis of Radix Notoginseng
5~15 parts of 5~15 parts of Cordyceps of 5~10 parts of Rhizoma Chuanxiongs of 5~10 parts of Ligamentum cervis of eupolyphage sece steleophaga
4~10 parts of Sanguis Draxonis
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011416254A CN1184992C (en) | 2001-09-29 | 2001-09-29 | Chinese patent medicine for treating paraplegia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011416254A CN1184992C (en) | 2001-09-29 | 2001-09-29 | Chinese patent medicine for treating paraplegia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1346675A true CN1346675A (en) | 2002-05-01 |
CN1184992C CN1184992C (en) | 2005-01-19 |
Family
ID=4676287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011416254A Expired - Fee Related CN1184992C (en) | 2001-09-29 | 2001-09-29 | Chinese patent medicine for treating paraplegia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1184992C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1308025C (en) * | 2005-03-10 | 2007-04-04 | 介晓东 | Medicine for treating paraplegia and its preparing method |
-
2001
- 2001-09-29 CN CNB011416254A patent/CN1184992C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1308025C (en) * | 2005-03-10 | 2007-04-04 | 介晓东 | Medicine for treating paraplegia and its preparing method |
Also Published As
Publication number | Publication date |
---|---|
CN1184992C (en) | 2005-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101732683A (en) | Chinese medicinal preparation for treating facial chloasma and preparation method thereof | |
CN1203805A (en) | Health-care drink capable of preventing and curing menopathy | |
CN1223359C (en) | Kidney-reinforcing blood-activating wine | |
CN101129852A (en) | Oral liquid for regulating the flow of Qi and pacifying the mind | |
CN105311492A (en) | Medicine for treating coronary atherosclerotic heart disease | |
CN1742626A (en) | Sea-buckthorn licorice tablet and preparing technology | |
CN1184992C (en) | Chinese patent medicine for treating paraplegia | |
CN100531789C (en) | Chinese medicine for treating injury | |
CN100411666C (en) | Broad-specturm medicine for treating snake venom poisoning | |
CN1285378C (en) | Nourishing wine for regulating human body balance function | |
CN101129512A (en) | Zegui oral liquid | |
CN1164294C (en) | Liver cancer resisting medicine | |
CN1129447C (en) | Anshen pill-treating cardio-cerebral angiopathy | |
CN101549057A (en) | Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same | |
CN101129610A (en) | Vitality raising pill of glutinous rehmannia | |
CN1259359A (en) | Xiongsanxian medicinal wine contg. bear bile and pseudo ginseng and its prepn. technology | |
CN1850160A (en) | Qidantongmai Tablet, and its preparing process | |
CN1262295C (en) | Health care medicine capable of strengthening heart and kidney function and immunologic function | |
CN1059120C (en) | Chinese medicine for treating bone wound | |
CN1062172C (en) | Medicine for treating cervical spondylopathy | |
CN1185007C (en) | Blood-lipid-reducing thrombolytic medicine | |
CN1186036C (en) | Diabetes treating medicine and its prepn | |
CN1209125C (en) | Diabetes treating medicine | |
CN1218738C (en) | Prepared Chinese internal medicine for promoting blood circulation to stop pain | |
CN1488382A (en) | Health-care medicine for preventing and curing cardio-cerebrovascular diseae |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |